1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Poland Pharmaceuticals and Healthcare Report Q4 2015

Poland Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 109 pages

Includes 3 FREE quarterly updates

BMI View: A positive economic outlook and strong pharmacy sales data for Poland in the first quarter of the year reaffirms our outlook for a pickup in pharmaceutical sales growth in 2015. With the National Health Fund expanding its reimbursement expenditure and Polish consumer confidence rising, we see Poland's pharmaceutical market as being one of the most promising within the Central and Eastern Europe region.

Headline Expenditure Projections

- Pharmaceuticals: PLN32.04bn (USD10.15bn) in 2014 to PLN33.39bn (USD8.91bn) in 2015; +4.2% in local currency terms and -12.2% in US dollar terms. Forecast unchanged from last quarter.
- Healthcare: PLN111.52bn (USD35.35bn) in 2014 to PLN115.73bn (USD30.90bn) in 2015; +3.8% in local currency terms and -12.6% in US dollar terms. Forecast in line with last quarter.

Table Of Contents

Poland Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2011-2019) 16
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2011-2019) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Poland 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2013-2019) 30
Macroeconomic Forecasts 31
Economic Analysis 31
Real GDP By Expenditure Components 31
Table: GDP By Expenditure (Poland 2012-2019) 34
Industry Risk Reward Ratings 35
Central And Eastern Europe Risk/Reward Index - Q4 2015 35
Poland Risk/Reward Index 41
Rewards 41
Risks 41
Market Overview 43
Industry Trends And Developments 44
Epidemiology 44
Healthcare Sector 45
Hospital Infrastructure 47
Ambulatory Infrastructure 47
Table: Civilian Outpatient Facilities, 2002-2009 48
Hospital Privatisation 48
Health Insurance 49
Table: Healthcare Resources (Poland 2009-2014) 52
Table: Healthcare Personnel (Poland 2009-2014) 52
Table: Healthcare Activity (Poland 2009-2014) 53
Distribution Channels 53
Table: Cefarm's Financial Indicators, 2007-2010 (PLN mn) 54
Research and Development 55
Clinical Trials 56
Medical Devices 57
Regulatory Development 60
Advertising Regulations 61
Other Regulatory Developments 62
Intellectual Property Regime 63
Pricing And Reimbursement Regime 65
Reimbursement Regime Changes 70
Competitive Landscape 74
Pharmaceutical Sector 74
Domestic Industry 74
Foreign Industry 75
Pharmaceutical Wholesale Sector 76
Pharmaceutical Retail Sector 78
Table: Number Of Pharmacies In Poland, 2004-2009 78
Company Profile 79
Polpharma 79
Bioton 82
GlaxoSmithKline 85
Eli Lilly 88
Gedeon Richter 90
Krka 93
Lek/Sandoz 95
Demographic Forecast 98
Table: Population Headline Indicators (Poland 1990-2025) 99
Table: Key Population Ratios (Poland 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (Poland 1990-2025) 100
Table: Population By Age Group (Poland 1990-2025) 100
Table: Population By Age Group % (Poland 1990-2025) 101
Glossary 103
Methodology 105
Pharmaceutical Expenditure Forecast Model 105
Healthcare Expenditure Forecast Model 105
Notes On Methodology 106
Risk/Reward Index Methodology 107
Index Overview 108
Table: Pharmaceutical Risk/Reward Index Indicators 108
Indicator Weightings 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.